Volgen
Stephan N.  Wagner
Stephan N. Wagner
Geverifieerd e-mailadres voor meduniwien.ac.at
Titel
Geciteerd door
Geciteerd door
Jaar
Involvement of chemokine receptors in breast cancer metastasis
A Müller, B Homey, H Soto, N Ge, D Catron, ME Buchanan, ...
nature 410 (6824), 50-56, 2001
70762001
A landscape of driver mutations in melanoma
E Hodis, IR Watson, GV Kryukov, ST Arold, M Imielinski, JP Theurillat, ...
Cell 150 (2), 251-263, 2012
29202012
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway, HR Widlund, MA Rubin, G Getz, AJ Berger, S Ramaswamy, ...
Nature 436 (7047), 117-122, 2005
17832005
High-throughput oncogene mutation profiling in human cancer
RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ...
Nature genetics 39 (3), 347-351, 2007
11592007
Melanoma genome sequencing reveals frequent PREX2 mutations
MF Berger, E Hodis, TP Heffernan, YL Deribe, MS Lawrence, ...
Nature 485 (7399), 502-506, 2012
8772012
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene
M Kim, JD Gans, C Nogueira, A Wang, JH Paik, B Feng, C Brennan, ...
Cell 125 (7), 1269-1281, 2006
5032006
Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence
KM Aird, G Zhang, H Li, Z Tu, BG Bitler, A Garipov, H Wu, Z Wei, ...
Cell reports 3 (4), 1252-1265, 2013
2842013
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
J Griss, W Bauer, C Wagner, M Simon, M Chen, ...
Nat Commun 10 (1), 4186, 2019
2742019
Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases
L Xu, SS Shen, Y Hoshida, A Subramanian, K Ross, JP Brunet, ...
Molecular Cancer Research 6 (5), 760-769, 2008
2732008
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by …
T Tuting, CC Wilson, DM Martin, YL Kasamon, J Rowles, DI Ma, ...
The Journal of Immunology 160 (3), 1139-1147, 1998
2701998
Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma
M Pashenkov, G Goëss, C Wagner, M Hörmann, T Jandl, A Moser, ...
Journal of Clinical Oncology 24 (36), 5716-5724, 2006
2562006
Integrative genome comparison of primary and metastatic melanomas
O Kabbarah, C Nogueira, B Feng, RM Nazarian, M Bosenberg, M Wu, ...
PloS one 5 (5), e10770, 2010
2552010
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2
JC Becker, P Terheyden, E Kämpgen, S Wagner, C Neumann, ...
British journal of cancer 87 (8), 840-845, 2002
1632002
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
BS Schulz, G Michel, S Wagner, R Süss, A Beetz, RU Peter, L Kemeny, ...
Journal of immunology (Baltimore, Md.: 1950) 151 (8), 4399-4406, 1993
1621993
Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.
JC Skipper, DJ Kittlesen, RC Hendrickson, DD Deacon, NL Harthun, ...
Journal of immunology (Baltimore, Md.: 1950) 157 (11), 5027-5033, 1996
1291996
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
R Somasundaram, G Zhang, M Fukunaga-Kalabis, M Perego, C Krepler, ...
Nature communications 8 (1), 607, 2017
1282017
Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma
SN Wagner, V Rebmann, CP Willers, H Grosse-Wilde, M Goos
The Lancet 356 (9225), 220-221, 2000
1242000
The role of oxidative stress in the pathogenesis and therapy of chronic wounds
J Dissemond, M Goos, SN Wagner
Der Hautarzt 53, 718-723, 2002
1192002
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
K Garg, M Maurer, J Griss, MC Brüggen, IH Wolf, C Wagner, N Willi, ...
Human pathology 54, 157-164, 2016
992016
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)
RG Meyer, CM Britten, U Siepmann, B Petzold, TA Sagban, HA Lehr, ...
Cancer Immunology, Immunotherapy 54, 453-467, 2005
882005
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20